Why Shares of NanoString Technologies Are Falling Thursday
Shares of NanoString Technologies (NASDAQ: NSTG) were down more than 16% Thursday morning and were down as much as 28.3% earlier in the day after the life sciences company lost a patent ruling in Germany. NanoString makes instruments and services to profile genes and proteins from tissue samples. The biotech company lost a patent court fight to 10x Genomics (NASDAQ: TXG) that forces NanoString to quit selling its CosMx Spatial Molecular Imager instruments and CosMx reagents for RNA detection in Germany.